Brands: Xylocaine Mpf · Lidocaine Hydrochloride
Average across 29 priced NDCs. A benchmark of pharmacy acquisition cost - not a retail quote.
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume - Medicaid only, not all-payer.
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Fresenius Kabi, USA LLC | generic | 20 | SUPPLYING |
| Lifestar Pharma LLC | unknown | 16 | SUPPLYING |
| Eugia US LLC | generic | 15 | SUPPLYING |
| Camber Pharmaceuticals, Inc. | generic | 9 | SUPPLYING |
| Hospira, Inc. | brand | 9 | SUPPLYING |
| Asclemed USA, Inc. | repackager | 6 | SUPPLYING |
| NorthStar RxLLC | relabeler | 5 | SUPPLYING |
| Anthea Pharma Private Limited | unknown | 5 | SUPPLYING |
| Medical Purchasing Solutions, LLC | repackager | 3 | SUPPLYING |
| Avenacy, LLC | unknown | 3 | SUPPLYING |
| Sportpharm LLC | repackager | 3 | SUPPLYING |
| Hikma Pharmaceuticals USA Inc. | generic | 2 | SUPPLYING |
| HF Acquisition Co. LLC, DBA HealthFirst | repackager | 2 | SUPPLYING |
| ProPharma Distribution | relabeler | 2 | SUPPLYING |
| Civica, Inc | unknown | 2 | SUPPLYING |
+ 3 more labelers
Shortages, recalls, and registration changes attached to this drug concept.
Lidocaine Hydrochloride Injection — reported in shortage by Eugia US LLC. Therapeutic category: Anesthesia.
Presence of Particulate Matter: The product was discolored and contained visible particulates (iron oxide) in the solution and embedded in the glass vial. — Recalling firm: Hospira Inc. — Nationwide
Presence of Particulate Matter- Confimed customer complaint of particulates embedded in glass container and in contact with product solution. — Recalling firm: Hospira Inc. — Nationwide
Lidocaine Hydrochloride Injection — reported in shortage by Hospira, Inc., a Pfizer Company. Therapeutic category: Analgesia/Addiction, Anesthesia, Pediatric.
